Quantum BioPharma Ltd. Number Of Share Options Exercised In Share-based Payment Arrangement
Quantum BioPharma Ltd. (QNTM) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 3719200.00% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2026-03-26
pure
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 6 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 3719200.00% 20-F · filed 2026-03-26 | |||
| 2025-09-30 | 3719200.00% 6-K · filed 2025-11-06 | |||
| 2025-06-30 | 3719200.00% 6-K · filed 2025-08-07 | |||
| 2024-09-30 | 144600.00% 6-K · filed 2025-11-06 | |||
| 2024-06-30 | -144600.00% 6-K · filed 2025-08-07 | |||
| 2023-12-31 | 32300.00% 20-F · filed 2026-03-26 | 2100000.00% 20-F · filed 2024-04-02 |
options
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 3 month | Number Of Share Options Exercised In Share-based Payment Arrangement 6 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | 37.19K options 20-F · filed 2026-03-26 | |||
| 2025-09-30 | 37.19K options 6-K · filed 2025-11-06 | |||
| 2025-06-30 | 37.19K options 6-K · filed 2025-08-07 | |||
| 2025-03-31 | 12.50K options 6-K/A · filed 2025-06-16 | |||
| 2024-09-30 | 1.45K options 6-K · filed 2025-11-06 | |||
| 2024-06-30 | 1.45K options 6-K · filed 2025-08-07 |